5 results match your criteria: "Osaka University of Pharmaceutical Sciences Osaka[Affiliation]"
Pharm Pract (Granada)
December 2019
PhD. Professor. Department of Social and Administrative Pharmacy, Osaka University of Pharmaceutical Sciences. Osaka (Japan).
Objectives: To develop a semi-quantitative instrument to assess pharmacists' confidence in medication counseling for patients with depression, The Pharmacists' Confidence scale about Medication Consultation for Depressive patients (PCMCD), and investigated its validity.
Methods: Following discussions with practicing pharmacists, we developed a 12-item questionnaire to assess pharmacists' confidence in medication counseling for patients with depression. We launched web-based cross-sectional survey during November and December 2018 to 77 pharmacists employed at drug chain stores in Kansai area.
Chimia (Aarau)
December 2018
Graduate School of Biomedical Sciences Nagasaki University, 1-14 Bunkyo-machi Nagasaki 852-8521, Japan.
The cyclopentene-based α,α-disubstituted α-amino acid Acc and its homopeptides, up to nonapeptides, were synthesized. The side-chain cyclopentene was expected to become symmetric, the C-carbon to be puckered, and other C, C, C, C-carbons to be coplanar. As expected, side-chain cyclopentene conformations became symmetric and C-carbons were puckered.
View Article and Find Full Text PDFFront Pharmacol
February 2017
Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences Osaka, Japan.
Nicotinic acetylcholine (nACh) receptors are implicated in the pathogenesis of epileptic disorders; however, the mechanisms of nACh receptors in seizure generation remain unknown. Here, we performed behavioral and immunohistochemical studies in mice and rats to clarify the mechanisms underlying nicotine-induced seizures. Treatment of animals with nicotine (1-4 mg/kg, i.
View Article and Find Full Text PDFFront Pharmacol
July 2016
Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences Osaka, Japan.
Synaptic vesicle glycoprotein 2A (SV2A) is specifically expressed in the membranes of synaptic vesicles and modulates action potential-dependent neurotransmitter release. To explore the role of SV2A in the pathogenesis of epileptic disorders, we recently generated a novel rat model (Sv2a(L174Q) rat) carrying a missense mutation of the Sv2a gene and showed that the Sv2a(L174Q) rats were hypersensitive to kindling development (Tokudome et al., 2016).
View Article and Find Full Text PDFFront Cell Neurosci
August 2013
Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences Osaka, Japan.
The inwardly rectifying potassium (Kir) channel Kir4.1 in brain astrocytes mediates spatial K(+) buffering and regulates neural activities. Recent studies have shown that loss-of-function mutations in the human gene KCNJ10 encoding Kir4.
View Article and Find Full Text PDF